The differential diagnosis of ovarian carcinomas, including secondary tumors, remains a challenging task. Mucinous carcinomas of the ovary are rare and can be easily confused with metastatic mucinous carcinomas that may present clinically as a primary ovarian tumor. Most of these originate in the gastrointestinal tract and pancreas. International Federation of Gynecology and Obstetrics (FIGO) stage is the single most important prognostic factor, and stage I carcinomas have an excellent prognosis; FIGO stage is largely related to the histologic features of the ovarian tumors. Infiltrative stromal invasion proved to be biologically more aggressive than expansile invasion. Metastatic colon cancer is frequent and often simulates ovarian endometrioid adenocarcinoma. Although immunostains for cytokeratins 7 and 20 can be helpful in the differential diagnosis, they should always be interpreted in the light of all clinical information. Occasionally, endometrioid carcinomas may exhibit a microglandular pattern simulating sex cord-stromal tumors. However, typical endometrioid glands, squamous differentiation, or an adenofibroma component are each present in 75% of these tumors whereas immunostains for calretinin and alpha-inhibin are negative. Endometrioid carcinoma of the ovary is associated in 15-20% of the cases with carcinoma of the endometrium. Most of these tumors have a favorable outcome and they most likely represent independent primary carcinomas arising as a result of a Mü llerian field effect. Although the criteria for distinguishing metastatic from independent primary carcinomas rely mainly upon conventional clinicopathologic findings, loss of heterozygosity and gene mutation analyses can be helpful. Transitional cell carcinomas are distinguished from undifferentiated carcinomas by the presence of thick, undulating papillae with smooth luminal borders, microspaces, and tumor cells with distinctive 'urothelial' appearance. Krukenberg tumors are metastatic adenocarcinomas traditionally perceived as composed of mucin-filled signet-ring cells associated with a striking proliferation of the ovarian stroma but many variations on this pattern occur.
In this presentation, eight different categories of primary and metastatic epithelial ovarian tumors that often pose a diagnostic challenge will be discussed ( Figure 1 ).
Mucinous carcinomas
Over the last 30 years, the establishment of the borderline subcategory of mucinous tumors, the increasing recognition of metastatic adenocarcinomas that resemble primary ovarian mucinous tumors, and the interpretation of most ovarian mucinous cystic tumors associated with pseudomyxoma peritonei as metastatic tumors from the appendix have reduced significantly the number of mucinous ovarian tumors currently diagnosed as carcinoma (Figure 2 ). Thus, for such tumors, the reported frequency of 15% is almost certainly an overestimation, and most recent studies have been based on a relatively small number of cases.
The tumors are bilateral in only 5% of the cases. Bilateral mucinous carcinomas or unilateral carcinomas o10 cm in greatest dimension should raise the suspicion of metastasis. 1 Over 80% of frankly invasive mucinous carcinomas have components of mucinous borderline tumor or mucinous cystadenoma or both, suggesting a progression from benign to malignant neoplasia and indicating the importance of extensive sampling as the malignant areas may involve only a small portion of the tumor. Recently, it has been proposed to divide mucinous carcinomas into two categories: an expansile type without demonstrable destructive stromal invasion, but exhibiting back-to-back or complex malignant glands without or with minimal intervening stroma and exceeding 10 mm 2 in area (43 mm in each of two linear dimensions) ( Figure 3) ; and an infiltrative type, characterized by obvious stromal invasion in the form of glands, cell clusters, or individual cells, disorderly infiltrating the stroma and frequently associated with a desmoplastic stromal reaction ( Figure 4) . 2 The expansile pattern of growth has also been referred in the literature as the 'noninvasive', 'intraglandular' 3 or 'confluent glandular' 4 pattern. Rare mucinous carcinomas of the endocervicallike or mixed Mü llerian type have been described recently; 5, 6 three of these cases were associated with endometriosis and one with an endocervical-like mucinous borderline tumor of the contralateral ovary. 6 
Differential Diagnosis
The most important differential diagnosis of mucinous ovarian carcinoma is with metastatic mucinous carcinoma that may present clinically as a primary ovarian tumor. Most of these originate in the large intestine, appendix, pancreas, biliary tract, stomach, or cervix. [7] [8] [9] [10] [11] Common features that favor a primary mucinous carcinoma are an expansile pattern of invasion and a complex papillary pattern (Figure 3) . 11 Features favoring a metastatic mucinous carcinoma include bilaterality, a multinodular growth pattern microscopically, ovarian surface involvement by epithelial cells (surface implants) ( Figure 5 ), and vascular space invasion. Extensive intra-abdominal spread of tumor, although sometimes seen with primary mucinous tumors, should always cause suspicion for a tumor metastatic to the ovary. 11 
Somatic Genetics
As indicated above, tumor heterogeneity is common and probably reflects the progression from benign to malignant neoplasia that often occurs in mucinous carcinogenesis. Recent studies have strongly suggested that in the sequence of malignant transformation from benign and borderline mucinous tumors to infiltrative carcinoma, intraepithelial (noninvasive) carcinomas and carcinomas with purely expansile (not obvious) invasion represent transitional stages of mucinous carcinogenesis. 2, 12 This hypothesis is also supported by the results of recent investigations of the genetic alterations occuring in ovarian mucinous tumors. [13] [14] [15] An increasing frequency of codon 12/13 K-ras mutations in benign, borderline tumors, and carcinomas has been reported, supporting that K-ras mutational activation is an early event in mucinous ovarian tumorigenesis ( Figure 6 ). [13] [14] [15] Using microdissection, we have detected the same K-ras mutation in separate areas exhibiting different histological grades within the same neoplasm in 15 mucinous tumors. 14 
Prognosis
International Federation of Gynecology and Obstetrics (FIGO) stage is the single most important prognostic factor, and stage I carcinomas have an excellent prognosis; however, the prognosis in cases with extraovarian spread is very poor. [2] [3] [4] 12, 16 Recent studies have clearly demonstrated that FIGO stage is largely related to the histologic features of the ovarian tumors. Infiltrative stromal invasion proved to be biologically more aggressive than expansile invasion. In two recent series totaling 59 cases of invasive carcinoma, 2,12 all 20 cases of carcinoma with expansile invasion and follow-up information were stage I and none of the patients had recurrent disease. Of the 25 infiltrative carcinomas with follow-up data, only nine of 13 patients with stage I disease and one of 12 with higher-stage disease (stage IIA) had a favorable outcome. Furthermore, in contrast to previous reports, [2] [3] [4] one of the two series 12 showed that high nuclear grade (grade 3) was predictive of behavior independent of the surgical stage.
The combination of extensive and infiltrative stromal invasion, high nuclear grade, and tumor rupture should be considered a strong predictor of recurrence for stage I mucinous carcinomas. 12 Foci of stromal invasion o10 mm 2 have been designated 'microinvasive,' and cases with such finding have had a favorable outcome. 2, 12 However, experience with these tumors is limited, and occasional carcinomas with stromal invasion barely beyond the limit accepted for microinvasion have produced metastases. 16 
Mural nodules in mucinous cystic tumors
Mucinous cystic tumors of the ovary, whether benign, borderline, or malignant, may contain one or more mural nodules that differ notably in their microscopic features from those of the underlying mucinous neoplasm. The nodules have been classified into three major subtypes: (a) sarcoma-like mural nodules; (b) nodules of anaplastic carcinoma; and (c) sarcoma. [17] [18] [19] [20] However, mixed nodules have also been described. 21 Sarcoma-like mural nodules occur predominantly in middle-aged women (mean age, 39 years) as redbrown nodules (0.6-6 cm in diameter), which appear sharply demarcated from the adjacent mucinous epithelium ( Figure 7 ). They are associated with mucinous carcinomas in about half the cases and with benign and borderline mucinous tumors in the remainder. The nodules are almost always multiple. They exhibit a heterogenous cell population characterized by numerous multinucleated cells of the epulis type, atypical spindle cells, and inflammatory cells (Figure 8 ). In some nodules, the predominant elements are spindle-shaped cells of moderate size containing hyperchromatic nuclei and pleomorphic mononucleated or binucleated giant cells. The mitotic index in the most cellular areas range from 5 to 10 per 10 high power fields (HPF). Immunohistochemical staining shows positivity for histiocyte markers and vimentin, with weak and focal staining for cytokeratins (CKs), suggesting a possible origin from submesothelial mesenchymal cells 20 possibly stimulated to proliferate as a result of spillage of mucin or hemorrhage into aggregates of these cells within the ovary. All of the lesions that have been accurately diagnosed have had a benign clinical course. 20 The nodules of anaplastic carcinoma are characterized by either a diffuse collection of large rhabdoid cells with abundant eosinophilic cytoplasm, eccentric nuclei, and one or more prominent nucleoli ( Figure 9 ); sarcomatoid spindle cells with atypical and vesicular nuclei often exhibiting a herringbone pattern; or pleomorphic cells. 22 CK immunostaining is usually strongly positive. These lesions are found almost always in malignant or borderline mucinous tumors, and very rarely in cystadenomas. Their size range from microscopic to about 10 cm. They may be single or multiple. Frequently, there is invasion of the surrounding tissue and, in a minority of cases, vascular space invasion as well. 18 Although they were first thought to carry an invariably unfavorable prognosis, recent data indicate that this does not necessarily apply to those found within unruptured stage I mucinous cystic tumors. 12, 22 Various types of true sarcomatous nodules have been reported, such as fibrosarcoma, rhabdomyosarcoma, and undifferentiated sarcoma. These tumors are associated with poor prognosis. Mixed nodules consist of usually small foci of anaplastic carcinoma within what appears to be a sarcoma-like mural nodule. Also, in tumors containing multiple nodules, some of them may be of one type and others of another type. 20 
Metastatic mucinous carcinomas
Mucinous tumors metastatic to the ovary may resemble primary ovarian tumors both grossly and microscopically. The metastases may be moderately differentiated or so well differentiated that they can be mistaken for mucinous borderline tumors even with foci that appear benign ( Figure 10 ). The primary tumors are usually in the large intestine, stomach, pancreas, or biliary tract. In addition to exhibiting the general features of metastatic tumors to the ovary (see above), these tumors are characterized by irregular infiltrative growth with desmoplasia, single cell invasion, signet-ring cells, and surface mucin. 11 Thorough sampling is crucial in identifying sometimes minor or major diagnostic clues.
Immunohistochemistry
Immunohistochemical stains can be helpful in distinguishing primary ovarian adenocarcinomas from metastatic carcinomas of the digestive system (Table 1) . CK immunostains are the most commonly used. Primary ovarian carcinomas are almost always immunoreactive for CK7 whereas colorectal adenocarcinomas are usually CK7 negative. 23, 24 Mucinous adenocarcinomas of the ovary may be immunoreactive for CK20, but the reaction is typically weak and focal. 9, 23 Endometrioid adenocarcinomas are almost invariably CK20 negative. 24 In contrast, colorectal adenocarcinomas are diffusely and strongly reactive for CK20. Therefore, a CK7-positive/CK20-negative immunoprofile favors a primary ovarian carcinoma, whereas a CK7-negative/CK20-positive suggests metastatic adenocarcinoma. 9, 25, 26 Although the vast majority of colorectal adenocarcinomas express CK20, poorly differentiated and right-sided tumors can be CK20 negative. 10 Furthermore, adenocarcinomas of the appendix, small intestine, and stomach can be CK7 positive. Thus, immunostains for CK7 and CK20 should be interpreted with caution, always in the light of all clinical information, and with the understanding that no tumor shows absolute consistency in its staining with these markers.
Other immunohistochemical stains have greater overlap in their expressions and should not be used individually in this differential diagnosis. Nevertheless, after taking into account the clinicopathologic findings and the results of the CK immunostains, negative stainings for vimentin, 27 CA125, gastric mucin gene MUC5AC 9 and human alveolar macrophage 56 (HAM56), 28 and strongly positive staining for carcinoembryonic antigen (CEA) 23, 24 favor metastatic colorectal cancer over primary ovarian adenocarcinoma. Likewise, strong immunoreactivity for P53 supports the colonic origin of the neoplasm.
Metastatic colon cancer of non-mucinous type
Most intestinal metastases originate in the large intestine and, much less frequently, in the small bowel. The ovarian tumors are bilateral in approximately two-thirds of the cases (Figure 11 ). Smaller tumors are usually solid, whereas larger tumors are composed of friable gray, yellow, or red tissue with cysts that contain necrotic tumor, mucinous fluid, or blood. 1, 29 Features that help to distinguish metastatic colon cancer from endometrioid carcinoma include luminal necrotic debris ('dirty necrosis'), focal segmental necrosis of the glands (Figure 12 ), occasional presence of goblet cells, and the absence of Mü llerian features (squamous differentiation, an adenofibromatous component, or association with endometriosis). Also the nuclei lining the glands of metastatic colon carcinoma exhibit a higher degree of atypia than those of endometrioid carcinoma. 1, 29 The stroma may be desmoplastic, edematous, or myxoid, but frequently resembles ovarian stroma. Stromal luteinization is most frequently found in metastatic colorectal carcinomas, and increased steroid hormone production in these patients often results in endocrine manifestations. Endometrioid adenocarcinomas simulating sex cord-stromal tumors Occasionally, endometrioid carcinomas contain solid areas punctuated by small rosette-like glands (microglandular pattern) simulating an adult granulosa cell tumor. 31 In other cases, a diffuse growth of cells in an endometrioid carcinoma may suggest the diffuse pattern of a granulosa cell tumor. The nuclei of endometrioid carcinomas are usually round and hyperchromatic, whereas those of granulosa cell tumors are round, oval, or angular, pale and grooved. 31 In yet other cases, endometrioid carcinomas may show focal to extensive areas resembling Sertoli and Sertoli-Leydig cell tumors ( Figure 13) . [31] [32] [33] They contain small, well-differentiated hollow tubules, solid tubules or, rarely, thin cords resembling sex cords. When the stroma is luteinized, this variant may be mistaken for a Sertoli-Leydig cell tumor, particularly in cases in which the patient is virilized (Figure 14) . Nevertheless, typical glands of endometrioid carcinoma, squamous differentiation, or an adenofibroma component are each present in 75% of the tumors, facilitating their recognition as an endometrioid carcinoma. 31 Furthermore, immunostains for alphainhibin ( Figure 15 ) and calretinin are positive in most neoplastic granulosa and Sertoli cells but negative in the cells of endometrioid carcinoma. 34 Contrariwise, positive EMA immunostains favor the diagnosis of carcinoma. 35 
Simultaneous endometrioid carcinomas of ovary and uterus
Endometrioid carcinoma of the ovary is associated in 15-20% of the cases with carcinoma of the endometrium. [36] [37] [38] The favorable outcome in those cases in which the tumor is limited to both organs suggests that these neoplasms are mostly independent primaries arising as a result of a Mü llerian field effect. 37, 38 The criteria for distinguishing metastatic from independent primary carcinomas rely mainly upon conventional clinicopathologic findings, namely stage, size, histologic type and grade of the tumors, the presence and extent of blood vessel, tubal, and myometrial invasion, bilaterality, and pattern of ovarian involvement, coexistence with endometrial hyperplasia, ovarian endometriosis or adenofibroma and, ultimately, patient follow-up ( Figure 16 ). 1, 38 By paying attention to these findings, the precise diagnosis can be established in most 
Independent versus metastatic tumors Figure 16 Criteria for distinguishing metastatic from independent primary carcinomas involving the endometrium and ovaries.
cases. In cases of endometrial carcinoma spreading to the ovaries, the latter organs usually exhibit surface involvement by multiple small tumor nodules and vascular space invasion, whereas the primary endometrial tumor often shows deep myometrial invasion and often extends through the fallopian tubes. Less frequently, an ovarian primary carcinoma produces metastasis to the endometrium. In such cases, the endomyometrial invasion may also occur as a direct extension from the ovarian tumor. Occasionally, however, the differential diagnosis may be difficult or impossible as the tumors may show overlapping features. In these cases, immunohistochemistry is of limited value as both tumors are adenocarcinomas and may exhibit similar profiles (CK, vimentin, CEA, CA12.5, CA19.9, or betacatenin) in both circumstances. The presence of identical aneuploid DNA indexes in two separate carcinomas suggests that one of them is a metastasis from the other; and, alternatively, when the two neoplasms have different DNA indexes, the possibility of two independent primaries has to be considered. 39 Nevertheless, the latter results do not exclude completely the metastatic nature of one of the two neoplasms; in fact, metastatic tumors, or even different parts of the same tumor, may exhibit DNA indexes that differ from those of their corresponding primary tumors as a consequence of tumor progression. 40 Therefore, DNA cytometry is also of limited value in the differential diagnosis.
Three molecular genetic methods have been used to determine clonality in synchronous carcinomas: X-chromosome inactivation, loss of heterozygosity (LOH), and gene mutation analyses. 41, 42 The most reliable methods are those addressed to study the molecular alterations that occur in early stage of tumor development. As a result of its many inconveniences, X-chromosome inactivation studies are far from ideal for assessing clonality. Although LOH pattern concordance in two separate carcinomas is highly suggestive of a common clonal origin (ie one tumor is a metastasis from the other), [41] [42] [43] the finding of different LOH patterns does not necessarily indicate that they represent independent tumors. Some studies have shown varying LOH patterns in different areas of the same tumor as a consequence of tumor heterogeneity. 43, 44 Another weakness of this approach is that in the absence of informative markers and the failure to detect LOH it is likely to underestimate the frequency of clonality. Consequently, LOH analysis is not the best way to assess monoclonality in neoplasia; nevertheless, it may be useful if the possibility of tumor evolution is taken into consideration. Mutation analysis of certain genes involved in early stages of tumorigenesis is an excellent method for assessing the relation of the ovarian and endometrial carcinomas in cases of synchronous tumors. [44] [45] [46] The comparative analyses have included microsatellite instability (MI), 45, 47 and CTNNB1 (Figure 17) , 45 K-ras, p53 43 and PTEN mutations. 46 Although these methods may be useful in individual cases, their results should be interpreted with caution, and always in concordance with the clinicopathologic findings. Discordant gene mutations and different MI patterns in the two neoplasms are suggestive of independent primary carcinomas; [44] [45] [46] nevertheless, metastatic carcinomas may also exhibit gene mutations that differ from those of their corresponding primary tumors as a result of tumor progression. 44, 48 Alternatively, two independent primary carcinomas may present identical gene mutations, reflecting induction of the same genetic abnormalities by a common carcinogenic agent acting in two separate sites of a single anatomic region. In other words, the genetic profile can be identical in independent tumors and different in metastatic carcinomas.
Malignant Brenner tumor and transitional cell carcinoma
Microscopically, malignant Brenner tumors are characterized by invasive transitional or squamous cell carcinoma, alone or mixed with each other, and a benign or borderline Brenner tumor component (Figure 18) . [49] [50] [51] [52] Mucinous elements and, more rarely, mucinous adenocarcinoma may coexist with the transitional component. However, pure mucinous carcinomas associated with a benign Brenner tumor should not be diagnosed as a malignant Brenner tumor. Malignant Brenner tumors are bilateral in 12% of cases.
Transitional cell carcinomas (TCCs) do not differ from other high-grade ovarian carcinomas regarding stage (often high) and bilaterality (15% of cases). [53] [54] [55] [56] TCCs resemble those occurring in the urinary tract and lack a benign or borderline Brenner tumor component. The tumor cells characteristically form undulating thick bands lining cysts (93%) ( Figure  19 ) or large papillae that protrude into empty spaces (63%) (Figure 20) . 56 The cysts, which are often compressed, appear empty or contain cellular necrotic debris; the papillae have cores of fibrovascular tissue and show a smooth luminal border ('papillary type'). [54] [55] [56] The bands of epithelium are multilayered, have a relative uniform width of at least a dozen cells, and typically contain microspaces of the size of or slightly larger than CallExner bodies (87%). 56 Diffuse (solid), insular, and trabecular patterns are encountered in approximately half of cases. Slit-like fenestrations or filiform papillae are seen focally in a minority of tumors. Tumor cell necrosis occurs in slightly over half of the cases. 56 At low magnification, the tumor cells usually appear monomorphic and evenly spaced. The nuclei are round and often exhibit large, eosinophilic nucleoli, or longitudinal grooves. 56 The cytoplasm is moderately abundant and frequently pale and granular. Generally, the degree of nuclear atypicallity is moderate or marked and mitotic activity is high. As in urothelial carcinoma, glandular and/or squamous differentiation may occur. Unlike malignant Brenner tumors, transitional cell carcinomas are frequently associated or mixed with carcinomas of other types, usually poorly differentiated serous or endometrioid carcinomas.
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Immunohistochemistry
Ovarian TCCs have an immunoprofile that differs from TCCs of the urinary tract and resembles that of ovarian epithelial stromal tumors. [57] [58] [59] Ovarian TCCs are negative for CK20, thrombomodulin, and uroplakin. Unlike bladder cancer, ovarian TCCs are positive for vimentin and CA125.
Differential Diagnosis
TCCs are distinguished from undifferentiated carcinomas by the presence of thick, undulating papillae with smooth luminal borders in contrast to the pseudopapillae secondary to tumor cell necrosis that may be present in undifferentiated carcinomas. Microspaces are also more frequent in TCC than in undifferentiated carcinomas. The tumor cells in TCCs have moderate cytoplasm, and in well-differentiated areas the nuclei have a distinctive 'urothelial' appearance with low cytoplasmic to nuclear ratios and nuclear grooves. 56 The adult type of granulosa cell tumor (AGCT) with a diffuse pattern may also be considered in the differential diagnosis. However, the microspaces of TCC are different from Call-Exner bodies; the former are larger and more variable in size and, in contrast to the latter, their lumens are sharply demarcated from the surrounding epithelial cells. 56 Also, the nuclei in TCC often have prominent nucleoli and high mitotic activity. Finally, the clinical and operative findings can be helpful. AGCTs are often associated with estrogenic manifestations, are unilateral in 95% of cases, and confined to the ovary (stage I) in 90% of the cases.
Prognosis
Most malignant Brenner tumors are stage I and have an excellent prognosis with an 88% 5-year survival; about one-fifth, however, present with extraovarian spread and behave similarly to other ovarian cancers. 53 Nevertheless, the prognosis of advanced stage malignant Brenner tumors was reported in one series to be better than that of transitional cell carcinomas. 53 It has been reported that carcinomas with transitional cell differentiation in their metastases usually behave more favorably than poorly differentiated carcinomas of the other types, apparently due to their better response to chemotherapy. 55 Other studies, however, have not confirmed these results. 60 The overall 5-year survival rate for TCC is 35%.
Krukenberg tumor
Krukenberg tumors are adenocarcinomas with a distinctive histologic appearance. They are traditionally perceived as composed of mucin-filled signet-ring cells associated with a striking proliferation of the ovarian stroma but many variations on this pattern are seen; 61, 62 signet-ring cells, although sometimes scant, are still definitional but a cellular stroma is not as requiring its presence would exclude otherwise typical tumors from the Krukenberg category. These tumors originate in the stomach in the vast majority of cases. Sometimes, the gastric cancer may be small and remains undetected for several years after oophorectomy. Much less frequently, the primary tumor is in the large intestine, breast, gallbladder, uterine cervix, appendix, or urinary bladder. In rare cases, the site of origin of the primary tumor is unknown and a diagnosis of 'primary Krukenberg tumor' has been proposed for those cases in which either the patient survives in good health for 10 years or longer or a thorough autopsy fails to reveal an extraovarian primary tumor. 1 Possibly, some of the cases reported in the older literature as 'primary Krukenberg tumors' represent mucinous (goblet cell) carcinoids. 63 Patients with Krukenberg tumors tend to be younger than most patients with metastatic carcinoma; most of them are between 40 and 50 years of age. Although the symptoms are usually nonspecific, endocrine manifestations, such as virilization during pregnacy, may result from stromal luteinization. 1 Krukenberg tumors are bilateral in at least 80% of the cases. 1 They are typically solid masses with smooth nodular or bosselated outer surfaces. The cut surfaces are usually predominantly white or tan ( Figure 21 ) with frequent areas of red or brown discoloration; the consistency may be firm, fleshy, or gelatinous. Because of the marked proliferation of the ovarian stroma, in some cases the tumors may resemble fibrothecomas on gross examination. Microscopically, some tumors are composed of multiple, ill-defined, and coalescent nodules, a pattern common to various types of metastatic ovarian tumor. A more typical pattern is characterized by juxtaposition of compact areas containing tumor cells, stromal elements or both, and pale edematous zones. Frequently, a pseudocapsule of compact tumor is seen between the ovarian surface epithelium and the central edematous zone ( Figure  22) . 62 The plump, rounded carcinoma cells often have a signet-ring appearance with vacuolated cytoplasm but some signet-ring cells have eosinophilic cytoplasm and some cells may appear nonspecific malignant cells. The epithelial cells may appear singly or in clusters ( Figure 23 ). Small glands, some of them appearing as microcysts, are usually found, as are larger glands and, occasionally, there is a predominant tubular architecture (tubular Krukenberg tumor). 61 The stromal cells are typically spindle shaped, and their degree of cellularity is variable, ranging from that of a normocellular ovarian fibroma to that of a cellular fibroma or fibrosarcoma to, conversely, that of an edematous fibroma. Some tumors are extensively luteinized. 1, 61 Krukenberg tumors must be distinguished from primary and other metastatic ovarian tumors that have mucin-rich signet-ring cells including clear cell adenocarcinoma, mucinous (goblet cell) carcinoid, and a variety of ovarian tumors that contain signet-ring-like cells filled with nonmucinous material. Ovarian clear cell adenocarcinoma may have a signet-ring cell component that simulates a Krukenberg tumor but the presence of the various distinctive patterns of clear cell carcinoma should resolve the problem. CK immunostains are not useful, as nearly half of gastric carcinomas metastatic to the ovary are CK7 positive/CK20 negative. 25 Mucinous carcinoid, either primary or metastatic, may contain large areas of signet-ring cells; the former neoplasms, however, frequently contain other teratomatous elements, and Grimelius stains as well as immunostains for chromogranin and synaptophysin are usually positive in both.
The tubular variant of Krukenberg tumor, when associated with stromal luteinization, can be confused with a Sertoli-Leydig cell tumor ( Figure 24) ; however, signet-ring cells are not a feature of the latter tumor except for the heterologous form that contains mucinous intestinal glands. 61 Positive mucicarmine and PAS stains with diastase digestion, the latter being more reliable, are of great value in establishing the diagnosis of a Krukenberg tumor. Occasional Krukenberg tumors may closely resemble fibromas on macroscopic examination and may have relatively few signet-ring cells. Bilaterality and positive mucin stains facilitate the diagnosis. 
